Brainsway Ltd. ADR (BWAY)
NASDAQ (NMS) NASDAQ (NMS) Primary 
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care
BrainsWay shares surge after the FDA cleared its accelerated Deep TMS protocol, offering faster depression treatment with strong clinical results.
BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care
BrainsWay's $5 million investment in Neurolief expands its mental health footprint with at-home depression treatment potential.
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Surging Earnings Estimates Signal Upside for Brainsway (BWAY) Stock
Brainsway Ltd. Sponsored ADR (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Think Brainsway (BWAY) Could Surge 25.58%: Read This Before Placing a Bet
The mean of analysts' price targets for Brainsway (BWAY) points to a 25.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
BrainsWay Ltd. (BWAY) Q2 2025 Earnings Call Transcript
BrainsWay Ltd. (NASDAQ:BWAY ) Q2 2025 Earnings Conference Call August 13, 2025 8:30 AM ET Company Participants Hadar Levy - Chief Executive Officer Ido Marom - Chief Financial Officer Conference Call Participants Carl Edward Byrnes - Northland Capital Markets, Research Division Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division Garth Russell - Unidentified Company Operator Good day, and welcome to the BrainsWay Second Quarter 2025 Earnings Conference Call.
Buy These 4 Stocks With Solid Net Profit Margin to Maximize Returns
Let's take a look at four stocks, CPRX, GAMB, ORN and BWAY, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.
Is the Options Market Predicting a Spike in Brainsway Stock?
Investors need to pay close attention to Brainsway stock based on the movements in the options market lately.
Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength?
Brainsway (BWAY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Are Medical Stocks Lagging Brainsway (BWAY) This Year?
Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable
Brainsway (BWAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
